Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · IEX Real-Time Price · USD

0.620

-0.044 (-6.70%)

At close: Jul 19, 2024, 4:00 PM

0.638

+0.018 (2.90%)

Pre-market: Jul 22, 2024, 7:35 AM EDT

Quoin Pharmaceuticals Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Net Income	-8.41	-8.69	-9.38	-21.46	-2.1	-1.56	Upgrade
Depreciation & Amortization	0.1	0.1	0.1	0.1	0.1	0.02	Upgrade
Share-Based Compensation	1.14	1.09	0.76	0	0	0	Upgrade
Other Operating Activities	-0.38	-0.38	0.03	15.64	0.65	0.24	Upgrade
Operating Cash Flow	-7.55	-7.86	-8.48	-5.72	-1.34	-1.3	Upgrade
Capital Expenditures	0	0	-0.25	-0.63	-0.13	0	Upgrade
Change in Investments	1.21	2.19	-9.9	0	0	0	Upgrade
Investing Cash Flow	1.21	2.19	-10.15	-0.63	-0.13	0	Upgrade
Share Issuance / Repurchase	5.48	5.85	14.88	10.1	0	0	Upgrade
Debt Issued / Paid	-0.68	-0.63	-0.87	3.17	0.86	0	Upgrade
Other Financing Activities	-	-	-	0.23	0.93	1.3	Upgrade
Financing Cash Flow	4.8	5.22	14.01	13.5	1.79	1.3	Upgrade
Net Cash Flow	-1.54	-0.46	-4.62	7.16	0.32	-0	Upgrade
Free Cash Flow	-7.55	-7.86	-8.73	-6.35	-1.46	-1.3	Upgrade
Free Cash Flow Per Share	-2.05	-7.97	-21.62	-0.24	-0.07	-0.07	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).